Demographic and clinical characteristics | N (%) |
---|---|
Adult tuberculosis source cases (N = 64) | |
Sputum smear(+)/culture (+) | 57 (89.1) |
Sputum smear(−)/culture(+) | 7 (10.9) |
Household contacts < 18 years of age (N = 230) | |
Male | 120 (52.2) |
Female | 110 (47.8) |
Age categories | |
Age < 2 years | 11 (4.8) |
Age 2–5 years | 38 (16.5) |
Age 5–10 years | 76 (33.1) |
Age ≥ 10 years | 105 (45.6) |
Tuberculosis prophylaxis at the evaluation | 11 (4.8) |
Isoniazid preventive chemotherapy | 7 (3) |
Rifampin preventive chemotherapy | 1 (0.4) |
Ethambutol preventive chemotherapy | 1 (0.4) |
Pyrazinamide preventive chemotherapy | 1 (0.4) |
Other TB preventive chemotherapy | 1 (0.4) |
Symptoms at entry to the study | |
Cough | 5 (2.2) |
Sputum | 5 (2.2) |
Weight loss | 2 (0.9) |
Fever | 1 (0.4) |
Chest pain | 3 (1.3) |